Esperanza Herreros

2.5k total citations
39 papers, 1.4k citations indexed

About

Esperanza Herreros is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Esperanza Herreros has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 13 papers in Infectious Diseases and 9 papers in Organic Chemistry. Recurrent topics in Esperanza Herreros's work include Malaria Research and Control (25 papers), Mosquito-borne diseases and control (13 papers) and HIV/AIDS drug development and treatment (9 papers). Esperanza Herreros is often cited by papers focused on Malaria Research and Control (25 papers), Mosquito-borne diseases and control (13 papers) and HIV/AIDS drug development and treatment (9 papers). Esperanza Herreros collaborates with scholars based in Spain, United Kingdom and Switzerland. Esperanza Herreros's co-authors include María Jesús Almela, Joël Lelièvre, Sonia Lozano, Domingo Gargallo‐Viola, Didier Leroy, Virginia Franco, Michael J. Delves, Federico G. De las Heras, Andrea Ruecker and Robert E. Sinden and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Esperanza Herreros

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esperanza Herreros Spain 20 691 324 304 251 238 39 1.4k
Jacob D. Johnson United States 23 875 1.3× 404 1.2× 213 0.7× 144 0.6× 222 0.9× 41 1.5k
Nobutaka Kato United States 17 603 0.9× 462 1.4× 260 0.9× 138 0.5× 254 1.1× 25 1.2k
Livia Vivas United Kingdom 23 802 1.2× 392 1.2× 605 2.0× 217 0.9× 331 1.4× 41 1.6k
Fátima Nogueira Portugal 23 712 1.0× 269 0.8× 323 1.1× 132 0.5× 175 0.7× 82 1.2k
Victoria Barton United Kingdom 14 738 1.1× 358 1.1× 316 1.0× 224 0.9× 330 1.4× 16 1.2k
Bärbel Bergmann Germany 20 752 1.1× 541 1.7× 120 0.4× 172 0.7× 133 0.6× 31 1.3k
Ursula Eckstein‐Ludwig United Kingdom 10 826 1.2× 401 1.2× 122 0.4× 150 0.6× 344 1.4× 11 1.3k
P. G. Bray United Kingdom 15 913 1.3× 310 1.0× 186 0.6× 202 0.8× 341 1.4× 19 1.3k
Fernando de Pilla Varotti Brazil 20 502 0.7× 415 1.3× 362 1.2× 91 0.4× 183 0.8× 90 1.4k
William Y. Ellis United States 19 610 0.9× 276 0.9× 449 1.5× 247 1.0× 176 0.7× 34 1.3k

Countries citing papers authored by Esperanza Herreros

Since Specialization
Citations

This map shows the geographic impact of Esperanza Herreros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esperanza Herreros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esperanza Herreros more than expected).

Fields of papers citing papers by Esperanza Herreros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esperanza Herreros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esperanza Herreros. The network helps show where Esperanza Herreros may publish in the future.

Co-authorship network of co-authors of Esperanza Herreros

This figure shows the co-authorship network connecting the top 25 collaborators of Esperanza Herreros. A scholar is included among the top collaborators of Esperanza Herreros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esperanza Herreros. Esperanza Herreros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reader, Janette, Mariëtte van der Watt, Jandeli Niemand, et al.. (2024). Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials. Nature Communications. 15(1). 9896–9896. 2 indexed citations
2.
Miguel-Blanco, Celia, James M. Murithi, Ernest Diez Benavente, et al.. (2021). The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957. Scientific Reports. 11(1). 1888–1888. 7 indexed citations
3.
Bueno, José M., Félix Calderón, Juan Carlos de la Rosa, et al.. (2018). Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5-Pyridinyl-4(1H)-Pyridones. Journal of Medicinal Chemistry. 61(8). 3422–3435. 16 indexed citations
4.
Lozano, Sonia, Pablo Gamallo, Carolina González‐Cortés, et al.. (2018). Gametocytes from K13 Propeller Mutant Plasmodium falciparum Clinical Isolates Demonstrate Reduced Susceptibility to Dihydroartemisinin in the Male Gamete Exflagellation Inhibition Assay. Antimicrobial Agents and Chemotherapy. 62(12). 9 indexed citations
5.
Miguel-Blanco, Celia, Irene T. Molina‐Martínez, Ana I. Bardera, et al.. (2017). Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nature Communications. 8(1). 15160–15160. 35 indexed citations
6.
Gómez-Lorenzo, Marı́a G., Joël Lelièvre, María Jesús Almela, et al.. (2016). A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents. Malaria Journal. 15(1). 385–385. 4 indexed citations
7.
Miguel-Blanco, Celia, Joël Lelièvre, Michael J. Delves, et al.. (2015). Imaging-Based High-Throughput Screening Assay To Identify New Molecules with Transmission-Blocking Potential against Plasmodium falciparum Female Gamete Formation. Antimicrobial Agents and Chemotherapy. 59(6). 3298–3305. 40 indexed citations
8.
Delves, Michael J., Andrea Ruecker, Ursula Straschil, et al.. (2013). Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs. Antimicrobial Agents and Chemotherapy. 57(7). 3268–3274. 128 indexed citations
9.
Bueno, José M., Esperanza Herreros, Íñigo Angulo‐Barturen, et al.. (2012). Exploration Of 4( 1H )-Pyridones As A Novel Family Of Potent Antimalarial Inhibitors Of The Plasmodial Cytochrome bc1. Future Medicinal Chemistry. 4(18). 2311–2323. 44 indexed citations
10.
Lelièvre, Joël, María Jesús Almela, Sonia Lozano, et al.. (2012). Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence “Transmission Blocking” Assay. PLoS ONE. 7(4). e35019–e35019. 186 indexed citations
11.
Bueno, José M., Pilar Manzano, Santiago Ferrer, et al.. (2011). Potent antimalarial 4-pyridones with improved physico-chemical properties. Bioorganic & Medicinal Chemistry Letters. 21(18). 5214–5218. 29 indexed citations
12.
Almela, María Jesús, et al.. (2010). In vitro absorption of 4(1H)-pyridone antimalarial derivative and its pro-drug using a Caco-2 model. Toxicology Letters. 196. S252–S252. 1 indexed citations
13.
Almela, María Jesús, et al.. (2009). Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives. Toxicology in Vitro. 23(8). 1528–1534. 4 indexed citations
14.
Prats, Clara, et al.. (2008). Effect of the haematocrit layer geometry on Plasmodium falciparum static thin-layer in vitro cultures. Malaria Journal. 7(1). 203–203. 9 indexed citations
15.
Casartelli, Alessandro, Esperanza Herreros, Dana T. Minnick, et al.. (2001). Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. Toxicology in Vitro. 15(4-5). 579–584. 90 indexed citations
16.
Herreros, Esperanza, María Jesús Almela, Sonia Lozano, Federico G. De las Heras, & Domingo Gargallo‐Viola. (2001). Antifungal Activities and Cytotoxicity Studies of Six New Azasordarins. Antimicrobial Agents and Chemotherapy. 45(11). 3132–3139. 44 indexed citations
17.
Herreros, Esperanza, et al.. (1998). XXII. Evaluation of drug efficacy by using animal models or in vitro systems. FEMS Immunology & Medical Microbiology. 22(1-2). 173–179. 5 indexed citations
18.
Herreros, Esperanza, et al.. (1997). Microplate Assays for in Vitro Evaluation of Anti‐Pneumocystis Drugs.. Journal of Eukaryotic Microbiology. 44(s6). 43S–44S. 5 indexed citations
19.
Ogawa, Haruko, Y Nozawa, Ryoji Tsuboi, et al.. (1992). Fungal enzymes in the pathogenesis of fungal infections. Medical Mycology. 30(s1). 189–196. 16 indexed citations
20.
Herreros, Esperanza, et al.. (1992). A reorganized Candida albicans DNA sequence promoting homologous non‐integrative genetic transformation. Molecular Microbiology. 6(23). 3567–3574. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob D. Johnson Breakdown of academic impact, for papers by Nobutaka Kato Breakdown of academic impact, for papers by Livia Vivas Breakdown of academic impact, for papers by Fátima Nogueira Breakdown of academic impact, for papers by Victoria Barton Breakdown of academic impact, for papers by Bärbel Bergmann Breakdown of academic impact, for papers by Ursula Eckstein‐Ludwig Breakdown of academic impact, for papers by P. G. Bray Breakdown of academic impact, for papers by Fernando de Pilla Varotti Breakdown of academic impact, for papers by William Y. Ellis
Rankless by CCL
2026